We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

AI Transforms Colonoscopy by Improving Detection and Reducing Missed Rates

By HospiMedica International staff writers
Posted on 06 Dec 2023
Print article
Image: AI-based colonoscopy methods can significantly improve detection of colorectal neoplasia (Photo courtesy of 123RF)
Image: AI-based colonoscopy methods can significantly improve detection of colorectal neoplasia (Photo courtesy of 123RF)

Colorectal cancer ranks among the top three most common types of cancer globally and is a significant factor in cancer-related deaths. A primary strategy to reduce colorectal cancer incidence involves early detection and removal of adenomatous polyps via colonoscopy. It's noted that a 1% increase in the adenoma detection rate typically corresponds to a 3% decrease in colorectal cancer risk. However, there's an estimated 27% rate of missed adenomas during endoscopy that can be attributed to cognitive or technical errors. Recently, the use of artificial intelligence (AI) has been explored to enhance polyp detection during colonoscopies, aiming to minimize human error. Despite this, inconsistencies in research outcomes concerning AI-based adenoma detection tools and concerns regarding overdiagnosis, which could lead to unnecessary patient stress and costs, persist.

In a new study, researchers at Harbin Medical University (Harbin, China) undertook an extensive review of randomized controlled trials to assess the pros and cons of AI-based systems in adenoma detection, comparing them with traditional colonoscopy methods. This thorough meta-analysis intended to deepen the understanding of AI-assisted detection of colorectal neoplasia. The findings revealed that AI-enhanced colonoscopy methods significantly improved the detection of colorectal neoplasia and markedly reduced the rates of missed adenomas and polyps. These AI-assisted studies also reported notable increases in both polyp and adenoma detection rates, including the average number of adenomas and polyps identified per colonoscopy procedure.

Specifically, the miss rate for polyps using AI-based colonoscopy methods was reduced by 52.5%, and the polyp detection rate was 23.8% higher compared to standard procedures. Additionally, the number of polyps discovered per colonoscopy was higher by 0.271 when utilizing AI-based methods. However, there was considerable variability in outcomes related to polyp detection across these studies. Likewise, the adenoma detection rate improved by 24.2%, and the adenoma miss rate decreased by 50.5% with AI methods. On average, 0.202 more adenomas were detected per colonoscopy using AI-enhanced detection techniques. Yet, these trials also displayed significant heterogeneity in their adenoma detection results.

The study findings indicate that AI-integrated colonoscopy could substantially improve adenoma and colorectal neoplasia detection rates. Minor enhancements in colonoscopy quality could lead to significant benefits in large-scale colorectal cancer screening programs, contributing to uniformity and improved quality in colonoscopy procedures. The research team believes there is a need for further long-term studies to validate the long-term effectiveness of AI-based colonoscopy methods in reducing the rates of morbidity and mortality associated with colorectal cancer.

Related Links:
Harbin Medical University

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Cardiograph
PageWriter TC10

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.